Nodal marginal zone B-cell lymphoma – Basic Information

Go back

Nodal marginal zone B-cell lymphoma is a rare type of slow-growing blood cancer that starts in the lymph nodes. This condition affects white blood cells called B lymphocytes, which are part of the body’s immune system. While the disease develops gradually, understanding its nature helps patients and their families navigate the journey ahead with greater confidence.

What is Nodal Marginal Zone B-Cell Lymphoma?

Nodal marginal zone B-cell lymphoma is a type of blood cancer that develops when lymphocytes, which are white blood cells that help fight infections, grow out of control. These lymphocytes travel throughout the body in the lymphatic system, a network of vessels and organs that forms part of the immune system. When you’re healthy, B lymphocytes, also known as B cells, help protect your body from germs and infections.[1]

This condition belongs to a larger family of cancers called non-Hodgkin lymphomas, which are separated from another group called Hodgkin lymphomas based on the types of cells they contain. Among non-Hodgkin lymphomas, nodal marginal zone lymphoma is classified as a low-grade or indolent type, meaning it grows slowly compared to more aggressive cancers.[3]

The name “marginal zone” comes from the specific location where this cancer begins. Inside lymph nodes and other lymphoid tissues, there are small structures called lymphoid follicles. These follicles have different zones or sections. The marginal zone wraps around another area called the mantle zone, sitting at the edge of normal lymphoid tissue collections. When B cells in this marginal zone change and become abnormal, they can multiply excessively, leading to this type of lymphoma.[3]

There are actually three different types of marginal zone lymphomas, and they are named based on where they develop in the body. Nodal marginal zone lymphoma specifically affects the lymph nodes, though it can also appear in the bone marrow. The other two types are extranodal marginal zone lymphoma, which is also called MALT lymphoma and affects areas outside the lymph nodes like the stomach or lungs, and splenic marginal zone lymphoma, which affects the spleen.[4]

Who Gets Nodal Marginal Zone Lymphoma?

Nodal marginal zone B-cell lymphoma is considered a rare condition. When looking at who is most likely to develop this disease, age appears to be an important factor. This type of lymphoma usually affects people who are 60 years old or older. It is less common to see this condition in younger adults or children.[3]

Gender also plays a role in who develops this disease. Research shows that marginal zone lymphomas, including the nodal type, tend to be more common in men than in women. However, both men and women can develop this condition, and the reasons for this difference are not fully understood.[3]

What Causes Nodal Marginal Zone Lymphoma?

The exact cause of nodal marginal zone B-cell lymphoma is not always clear, but researchers have identified several factors that may contribute to its development. Understanding what might trigger the disease helps doctors identify people who may be at higher risk.

One important factor is the presence of certain viral infections. Nodal marginal zone lymphoma has been associated with hepatitis C virus infection. When someone has hepatitis C, their immune system is constantly fighting the infection, and this ongoing activation may create conditions that allow lymphoma cells to develop.[3][5]

Autoimmune diseases also appear to play a role in causing this type of lymphoma. In autoimmune conditions, the body’s immune system mistakenly attacks its own tissues, leading to chronic inflammation. This constant state of immune system activation may increase the risk of lymphocytes becoming cancerous over time.[3]

Family history is another factor that doctors consider. People with a family history of lymphoma may have a higher chance of developing nodal marginal zone lymphoma, suggesting that genetics might play some role in who gets this disease.[3]

⚠️ Important
If you have nodal marginal zone lymphoma and also have hepatitis C virus infection, your doctor will likely treat the hepatitis C first with antiviral drugs. Treating the viral infection before starting cancer treatment can sometimes reduce the symptoms of lymphoma, and in some cases, you may not need any additional treatment for the lymphoma right away.[5]

Risk Factors for Developing This Disease

Certain groups of people and specific health conditions increase the likelihood of developing nodal marginal zone B-cell lymphoma. These risk factors don’t guarantee that someone will develop the disease, but they signal that extra attention may be needed.

Having a family history of lymphoma is a significant risk factor. If blood relatives have had lymphoma, the risk of developing marginal zone lymphoma appears to be higher, though the disease itself is not directly inherited in a simple pattern.[3]

Chronic infections represent another important risk category. In particular, hepatitis C virus infection is linked to nodal marginal zone lymphoma. The prolonged presence of the virus in the body creates ongoing immune system stimulation, which may eventually lead to lymphoma development.[5]

People with autoimmune disorders face an elevated risk as well. Conditions where the immune system attacks the body’s own tissues create an environment of constant inflammation and immune cell activation. This chronic stimulation of immune cells, including B lymphocytes, may contribute to the development of lymphoma over time.[3]

Age is a risk factor that cannot be changed. Since nodal marginal zone lymphoma typically affects people over 60, getting older naturally increases the risk. This may be because the immune system changes with age, or because of accumulated exposures to various triggers over a lifetime.[3]

Signs and Symptoms

Nodal marginal zone B-cell lymphoma typically grows very slowly, which means that many people may have the condition for some time without experiencing any symptoms. When symptoms do appear, they can vary from person to person, but there are some common patterns that doctors look for.

The most noticeable symptom is often swollen lymph nodes. These swollen nodes may appear in the neck, underarms, or groin area. The lymph nodes might feel like small lumps under the skin, and they are usually painless. Because the lymphoma primarily affects the lymph nodes, this swelling is one of the key signs that doctors watch for during physical examinations.[10]

Some people experience what doctors call “B symptoms,” which are three specific signs that indicate the body is responding to the lymphoma. These include fever that comes and goes without an obvious cause like an infection, night sweats that are severe enough to soak through clothing and bedding, and unexplained weight loss where a person loses a significant amount of weight without trying to do so.[3]

Fatigue is another symptom that some patients report. This isn’t just ordinary tiredness that gets better with rest; it’s a persistent feeling of exhaustion that can interfere with daily activities and doesn’t improve even after sleeping well.

Because nodal marginal zone lymphoma can also affect the bone marrow, some people may notice symptoms related to changes in their blood counts. However, many patients may not have obvious symptoms at all, and the disease might be discovered during routine blood tests or examinations for other reasons.[5]

How Can Nodal Marginal Zone Lymphoma Be Prevented?

Unfortunately, there is no known way to completely prevent nodal marginal zone B-cell lymphoma. Since the exact causes are not fully understood, and many risk factors like age and family history cannot be changed, prevention strategies are limited.

However, taking steps to reduce known risk factors may help lower the chances of developing this condition. For people with hepatitis C infection, getting treated for the virus may reduce the risk of developing nodal marginal zone lymphoma. Hepatitis C is treatable with antiviral medications, and eliminating the infection removes one of the known triggers for this type of lymphoma.[5]

Managing autoimmune diseases with appropriate medical care may also help reduce risk, though this connection is not completely clear. Working closely with doctors to control inflammation and keep the immune system as stable as possible is good practice for overall health.

Regular medical check-ups are important, especially for people who have risk factors like family history of lymphoma or chronic infections. While these check-ups cannot prevent the disease, they can help catch it early if it does develop, which may lead to better treatment outcomes.

Living a generally healthy lifestyle by maintaining a balanced diet, exercising regularly, avoiding smoking, and limiting alcohol intake supports overall immune system health. While these steps cannot guarantee prevention of lymphoma, they contribute to better health overall and may help the body resist various diseases.

How Nodal Marginal Zone Lymphoma Affects the Body

Understanding what happens in the body when nodal marginal zone B-cell lymphoma develops helps explain why symptoms occur and how the disease progresses. The changes begin at the cellular level but eventually affect how the body functions.

The disease starts when B lymphocytes in the marginal zone of lymph nodes undergo changes, or mutations. These mutations cause the cells to behave abnormally. Instead of growing, dividing, and dying in a controlled way like normal cells, the mutated B cells multiply excessively and don’t die when they should. This leads to an accumulation of abnormal lymphocytes.[3]

As these abnormal cells build up, they form tumors in the lymph nodes, causing them to swell. The lymph nodes are small, bean-shaped structures scattered throughout the body that normally filter lymph fluid and house immune cells. When they become packed with lymphoma cells, they enlarge and can be felt as lumps under the skin.

The lymphoma cells can also travel through the lymphatic system and blood to other parts of the body. When they reach the bone marrow, which is the spongy tissue inside bones where blood cells are made, they can interfere with normal blood cell production. This might lead to lower counts of red blood cells, white blood cells, or platelets, though this doesn’t happen in all cases.

Because nodal marginal zone lymphoma is slow-growing, the body often compensates for these changes initially. This is why many people don’t have symptoms in the early stages. However, as the disease progresses and more lymph nodes become involved, or if the bone marrow becomes significantly affected, symptoms begin to appear.

The immune system’s normal function can be disrupted by the presence of these abnormal B cells. Since B lymphocytes normally help fight infections by producing antibodies, having a large number of abnormal B cells that don’t work properly can weaken the immune response. This may make people more susceptible to infections over time.

In some cases, nodal marginal zone lymphoma can transform into a more aggressive type of lymphoma called diffuse large B-cell lymphoma. This transformation means the slow-growing cancer changes into a faster-growing form that requires different treatment approaches. When this happens, symptoms may appear more suddenly and be more severe.[5]

⚠️ Important
Sometimes nodal marginal zone lymphoma can change into a more aggressive type of lymphoma called diffuse large B-cell lymphoma. This transformation changes how the disease behaves and how it needs to be treated. If this happens, your healthcare team will adjust your treatment plan accordingly to address the more aggressive form of the disease.[5]

Ongoing Clinical Trials on Nodal marginal zone B-cell lymphoma

  • Study of Obinutuzumab as First-Line Treatment for Adult Patients with Marginal Zone Lymphoma Who Are Not Eligible for Local Therapy

    Not recruiting

    1 1 1
    Investigated drugs:
    Germany
  • Study on Copanlisib and Rituximab for Patients with Marginal Zone Lymphoma Needing Treatment After Local Therapy Failure or Relapse

    Not recruiting

    1 1 1
    Germany
  • Study on Lisocabtagene Maraleucel for Adults with Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma

    Not recruiting

    1 1
    Investigated drugs:
    Austria France Germany Italy Spain Sweden

References

https://lymphoma-action.org.uk/types-lymphoma-non-hodgkin-lymphoma/nodal-marginal-zone-lymphoma

https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/lymphoma/non-hodgkin-lymphoma/nodal-marginal-zone-lymphoma/

https://my.clevelandclinic.org/health/diseases/24915-marginal-zone-lymphoma

https://www.mayoclinic.org/diseases-conditions/marginal-zone-lymphoma/symptoms-causes/syc-20586112

https://cancer.ca/en/cancer-information/cancer-types/non-hodgkin-lymphoma/treatment/treatment-by-type/nodal-marginal-zone-lymphoma

https://www.macmillan.org.uk/cancer-information-and-support/lymphoma/non-hodgkin/types/nodal-marginal-zone-b-cell

https://www.mdanderson.org/cancerwise/4-things-to-know-about-marginal-zone-lymphoma.h00-159620223.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC10469082/

https://lymphoma-action.org.uk/types-lymphoma-non-hodgkin-lymphoma/nodal-marginal-zone-lymphoma

https://www.mayoclinic.org/diseases-conditions/marginal-zone-lymphoma/diagnosis-treatment/drc-20586125

https://www.lymphoma.org/understanding-lymphoma/aboutlymphoma/nhl/mzl/mzltreatment/

https://cancer.ca/en/cancer-information/cancer-types/non-hodgkin-lymphoma/treatment/treatment-by-type/nodal-marginal-zone-lymphoma

https://my.clevelandclinic.org/health/diseases/24915-marginal-zone-lymphoma

https://www.macmillan.org.uk/cancer-information-and-support/lymphoma/non-hodgkin/types/nodal-marginal-zone-b-cell

https://www.mdanderson.org/cancerwise/4-things-to-know-about-marginal-zone-lymphoma.h00-159620223.html

https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/lymphoma/non-hodgkin-lymphoma/nodal-marginal-zone-lymphoma/

https://lymphoma-action.org.uk/types-lymphoma-non-hodgkin-lymphoma/nodal-marginal-zone-lymphoma

https://www.mdanderson.org/cancerwise/4-things-to-know-about-marginal-zone-lymphoma.h00-159620223.html

https://www.mayoclinic.org/diseases-conditions/marginal-zone-lymphoma/diagnosis-treatment/drc-20586125

https://www.macmillan.org.uk/cancer-information-and-support/lymphoma/non-hodgkin/types/nodal-marginal-zone-b-cell

https://healthtree.org/marginal-zone-lymphoma/community/how-long-will-i-live-with-marginal-zone-lymphoma

https://my.clevelandclinic.org/health/diseases/24915-marginal-zone-lymphoma

https://cancer.ca/en/cancer-information/cancer-types/non-hodgkin-lymphoma/treatment/treatment-by-type/nodal-marginal-zone-lymphoma

https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/lymphoma/non-hodgkin-lymphoma/nodal-marginal-zone-lymphoma/

https://www.lymphoma.org/understanding-lymphoma/aboutlymphoma/nhl/mzl/mzltreatment/

FAQ

Is nodal marginal zone B-cell lymphoma curable?

Nodal marginal zone B-cell lymphoma is a slow-growing cancer that healthcare providers can treat. Some types of marginal zone lymphoma can be cured with treatment. Because this is an indolent lymphoma, many patients live for many years with the disease, and treatment options are available when needed.[3]

What happens if I have hepatitis C and nodal marginal zone lymphoma?

If you have both conditions, your doctor will likely treat the hepatitis C infection first with antiviral drugs before starting any cancer treatment. Treating hepatitis C can sometimes reduce the symptoms of the lymphoma, and you may not need additional treatment right away. This approach takes advantage of the connection between the viral infection and the lymphoma.[5]

Why is it called “slow-growing” or “indolent” lymphoma?

Nodal marginal zone lymphoma is called slow-growing or indolent because it develops very gradually over time, rather than rapidly like some other cancers. This means symptoms may not appear for a long time, and the disease may not require immediate treatment. Many people can live with this type of lymphoma for years while doctors monitor it closely.[3]

What is “watchful waiting” and why is it used for this disease?

Watchful waiting, also called active surveillance, is an approach where doctors carefully monitor the lymphoma without starting treatment right away. This strategy is used because nodal marginal zone lymphoma grows slowly and may not cause problems for a long time. Treatment begins only when symptoms appear or tests show the disease is progressing. This avoids unnecessary treatment side effects while the disease is stable.[5]

Can nodal marginal zone lymphoma spread to other parts of the body?

Yes, nodal marginal zone lymphoma can spread from the lymph nodes to other areas. It commonly affects the bone marrow and blood in addition to lymph nodes. Sometimes it can transform into a more aggressive type of lymphoma called diffuse large B-cell lymphoma, which requires different treatment.[5]

🎯 Key Takeaways

  • Nodal marginal zone B-cell lymphoma is a rare, slow-growing blood cancer that typically affects people over 60 and is more common in men than women.
  • The disease gets its name from developing in the “marginal zone,” which is the outer edge of lymphoid tissue inside lymph nodes.
  • Hepatitis C infection is linked to this lymphoma, and treating the virus first can sometimes reduce lymphoma symptoms without additional cancer treatment.
  • Many people with this condition don’t have symptoms initially because the cancer grows so slowly, and it may be discovered during routine medical exams.
  • Watchful waiting is a common approach where doctors monitor the disease without immediate treatment, starting therapy only when symptoms appear or the disease progresses.
  • The most common symptom is painless swelling of lymph nodes in the neck, underarms, or groin, though some people also experience fever, night sweats, and unexplained weight loss.
  • This lymphoma can sometimes transform into a more aggressive form called diffuse large B-cell lymphoma, which changes how the disease is treated.
  • There is no known way to prevent this disease, but managing risk factors like hepatitis C infection and autoimmune diseases may help reduce risk.